









Markets
/
Stocks
/
nasdaq-avte
/

Aerovate Therapeutics Inc

AVTE

2.680USD

0.000

Close 12/19, 16:00（ET）Quotes delayed by 15 min

77.68MMarket Cap

LossP/E TTM



Aerovate Therapeutics Inc

2.680

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Aerovate Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

Total equity

Cash, cash equivalents and short-term investments

--76.21M

--78.62M

- Cash and cash equivalents

--44.22M

--33.75M

-Short-term investments

--31.99M

--44.87M

Prepaid expenses

--318.00K

--649.00K

Other current assets

--845.00K

Total current assets

--77.37M

--80.12M

Non-current assets

Net Fixed Assets

--160.00K

--215.00K

Other non-current assets

--0.00

Total assets

--77.53M

--80.33M

Liabilities

Current liabilities

-Other payables

--318.00K

--649.00K

Accrued expenses

--1.72M

--2.54M

Other current liabilities

--318.00K

--649.00K

Total current liabilities

--2.42M

--3.83M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Other non-current liabilities

--70.00K

Total liabilities

--2.49M

--3.90M

Shareholders' equity

Common equity

--310.57M

--309.38M

Retained earnings

---235.57M

---233.05M

Capital reserves

--310.56M

--309.38M

Gains losses not affecting retained earnings

--50.00K

--105.00K

Total equity

--75.05M

--76.43M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

